Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.84%
1,097.09
-9.27
-0.84%
—1,106.361,105.681,109.291,097.05——
SIXC
Communications
SIXC
Communications
SIXC
+0.45%
613.02
+2.73
+0.45%
—610.29610.29614.07610.29——
SIXE
Energy
SIXE
Energy
SIXE
+0.33%
1,215.25
+4.03
+0.33%
—1,211.221,211.011,220.571,209.79——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.38%
1,744.09
-6.62
-0.38%
—1,750.711,753.101,762.131,743.30——
SIXM
Financials
SIXM
Financials
SIXM
+0.41%
630.75
+2.58
+0.41%
—628.17629.38633.75629.38——
SIXR
Staples
SIXR
Staples
SIXR
+0.24%
856.62
+2.05
+0.24%
—854.57855.71859.22855.71——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.05%
216.77
-0.100
-0.05%
—216.87216.87217.75216.17——
SIXT
Technology
SIXT
Technology
SIXT
+1.14%
3,602.37
+40.43
+1.14%
—3,561.943,571.443,605.343,562.15——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.01%
903.23
-0.080
-0.01%
—903.31903.26906.56901.88——
SIXV
Health care
SIXV
Health care
SIXV
-0.08%
1,480.36
-1.18
-0.08%
—1,481.541,482.481,488.461,474.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.09%
2,402.19
+2.24
+0.09%
—2,399.952,404.452,412.722,401.61——
BMRN:NASDAQ
Biomarin Pharmaceutical Inc
$52.95
-1.12%
(-0.60) 1D
May 14, 10:41:24 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BMRN...
Open
$53.78
High
$54.09
Low
$52.64
Mkt. cap
10.30B
Avg. vol.
1.75M
Volume
139.75K
P/E ratio
38.64
52-wk high
$66.28
52-wk low
$50.76
EPS
$1.37
Beta
0.23
Shares outstanding
193.28M
No. of employees
3K
News stories
From sources across the web
Profile
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria. Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials. Wikipedia
About Biomarin Pharmaceutical Inc
CEOAlexander Hardy
Employees3.22K
FoundedMar 1997
HeadquartersSan Rafael, California, United States
SectorBiotechnology
Websitebiomarin.com
Last report
May 4, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
$0.76 / $0.91
-16.86%miss
Revenue / Est. (USD)
766.21M / 751.68M
+1.93%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
825.41M
776.13M
874.56M
766.21M
Cost of goods sold
311.40M
549.56M
348.91M
373.80M
Cost of revenue
311.40M
549.56M
348.91M
373.80M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
232.28M
268.42M
324.16M
249.98M
Operating expense
237.12M
273.26M
329.01M
254.46M
Total operating expenses
548.52M
822.82M
677.92M
628.26M
Operating income
276.89M
-46.69M
196.64M
137.95M
Other non operating income
4.83M
5.09M
1.02M
3.96M
EBT including unusual items
297.87M
-26.32M
-27.15M
141.20M
EBT excluding unusual items
297.87M
-26.32M
214.10M
149.52M
Income tax expense
57.34M
4.42M
19.42M
35.68M
Effective tax rate
19.25%
-16.79%
-71.52%
25.27%
Other operating expenses
-
-
-
-
Net income
240.53M
-30.74M
-46.57M
105.53M
Net profit margin
29.14%
-3.96%
-5.33%
13.77%
Earnings per share
1.44
0.12
0.46
0.76
Interest and investment income
18.83M
17.85M
19.21M
22.56M
Interest expense
-2.68M
-2.58M
-2.78M
-14.96M
Net interest expenses
16.15M
15.28M
16.43M
7.60M
Depreciation and amortization charges
-
-
-
-
EBITDA
295.45M
-28.20M
209.68M
154.36M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer